AMALFITANO ANDREA ET AL: "Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial", GENETICS IN MEDICINE, WILLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 3, no. 2, 1 March 2001 (2001-03-01), pages 132-138, XP002184189, ISSN: 1098-3600, DOI: 10.1097/00125817-200103000-00008 (B1)

Johan Van Hove ET AL: "High-level production of recombinant human lysosomal acid a-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease", Proceedings of the National Academy of Sciences of the United States of America [H.W. Wilson - GS], 9 January 1996 (1996-01-09), pages 65-70, XP055133632, DOI: 10.1073/pnas.93.1.65 Retrieved from the Internet: URL:http://search.proquest.com/docview/230 227321 (B1)

MARTINIUK F ET AL: "Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFRneg cell line", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 276, no. 3, 5 October 2000 (2000-10-05), pages 917-923, XP002262096, ISSN: 0006-291X, DOI: 10.1006/BBRC.2000.3555 (B1)

MCVIE-WYLIE A J ET AL: "Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, AMSTERDAM, NL, vol. 94, no. 4, 1 August 2008 (2008-08-01) , pages 448-455, XP022833455, ISSN: 1096-7192, DOI: 10.1016/J.YMGME.2008.04.009 [retrieved on 2008-06-05] (B1)

WO-A2-2013/016249 (B1)

US-A1- 2011 268 721 (B1)

US-A1- 2011 300 120 (B1)

WO-A2-2005/077093 (B1)

WO-A2-2013/013017 (B1)

US-A1- 2005 058 634 (B1)